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Abstract
Comprehensive gas chromatography - mass spectrometry (GCxGC-MS) provides a different perspective in metabolomics
profiling of samples. However, algorithms for GCxGC-MS data processing are needed in order to automatically pro-
cess the data and extract the purest information about the compounds appearing in complex biological samples. This
study shows the capability of independent component analysis - orthogonal signal deconvolution (ICA-OSD), an al-
gorithm based on blind source separation and distributed in an R package called osd, to extract the spectra of the
compounds appearing in GCxGC-MS chromatograms in an automated manner. We studied the performance of ICA-
OSD by the quantification of 38 metabolites through a set of 20 Jurkat cell samples analyzed by GCxGC-MS. The
quantification by ICA-OSD was compared with a supervised quantification by selective ions, and most of the R2 coef-
ficients of determination were in good agreement (R2>0.90) while up to 24 cases exhibited an excellent linear relation
(R2>0.95). We concluded that ICA-OSD can be used to resolve co-eluted compounds in GCxGC-MS.
Keywords: comprehensive gas chromatography, orthogonal signal deconvolution, multivariate curve resolution,
compound deconvolution, independent component analysis.
1. Introduction1
Metabolomics is the study of low molecular weight compounds in biological systems [1]. Particularly, metabolomics2
focuses on comparing healthy versus metabolomic disease organisms and, therefore, it attempts to discover predic-3
tive biomarkers by detecting early biochemical changes before the appearance of the disease [2]. For that purpose,4
metabolomics experimental designs include non-targeted analysis of the samples as there is no prior knowledge of5
the metabolites that may be involved not only in fully developed metabolomic diseases, but also in pre-symptomatic6
stages.7
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Analytical techniques to identify and quantify metabolites include the best-established gas chromatography-mass8
spectrometry (GC-MS). Gas chromatography separates the compounds contained in a sample while passing through a9
chromatographic column. However, when two or more compounds do not completely separate chromatographically,10
those compounds are known to be co-eluted, and this clearly affects the correct quantification and identification of the11
metabolites. In that sense, comprehensive gas chromatography - mass spectrometry (GCxGC-MS) [3, 4] was devised12
to minimize co-elution. In GCxGC-MS, the sample pass through two chromatographic columns with orthogonal13
polarity properties, which improves the compound separation and it leads to an increased compound detection capacity14
as co-elution is diminished.15
However, compounds in the samples usually appear at trace levels and different sources of noise derived from16
the instrument and the sample biological matrix may interfere with the correct identification of the compounds. In17
the same way, GCxGC-MS generates large quantity of data and its interpretation can not be conducted manually. In18
that sense, GCxGC-MS data processing algorithms are needed to turn the chromatographic signals into interpretable19
biological information. Besides, GCxGC-MS samples are composed by a large amount of data in comparison with20
GC-MS samples, and algorithms for GCxGC-MS data processing should be optimized for a fast data processing.21
As reviewed in [5], some of the existing data processing algorithms that can be applied to resolve mixtures in22
comprehensive gas chromatography include PARAFAC [6] and multivariate curve resolution - alternating least squares23
(MCR-ALS) [7]. Contrarily to MCR, PARAFAC can be only applicable to a three-way data set, i.e., PARAFAC can24
not resolve a single GCxGC-MS sample.25
In the past years, independent component analysis (ICA) [8] has been introduced as an alternative to the traditional26
MCR for GC-MS data analysis [9, 10, 11]. ICA is a blind source separation (BSS) technique used to separate linearly27
mixed sources, i.e., it is capable of separating and retrieve the original compound sources - elution profile or spectra28
- from a mass spectra chromatogram. Whereas MCR–ALS resolves a chromatographic mixture by minimizing the29
residual error between the data and the predicted model, ICA uses another type of measure which is the statistical30
independence, and it estimates the original compound sources by maximizing the independence between components.31
ICA is widely applied in biomedical sciences, including data processing in electroencephalography recordings [12,32
13, 14], and it is also one of the most reported algorithms for resolution of spectroscopy mixtures. More recently, we33
have developed a new method known as independent component analysis - orthogonal signal deconvolution (ICA-34
OSD) [15], embedded in an R package, that uses a combination of ICA and principal component analysis (PCA)35
to identify co-eluted compounds in GC-MS. In ICA-OSD, PCA is proposed as an alternative to the typical use of36
least squares (LS) in MCR-ALS. The application of LS for spectra extraction has different drawbacks, detailed in37
[15], which can be summarized in the fact that no correlation or covariance information is taken into account when38
applying LS, and therefore LS may find difficulties in distinguishing noise and the different compound fragments. This39
may lead to introducing a bias into the LS regressors specially in situations of co-elution or under undue biological40
matrix interference. Besides, whereas the current ICA-based methods consider the spectra as the independent source41
in the chromatograms, in ICA-OSD we implemented a different approach where we assumed that the elution profile42
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was the independent source, as opposite to the spectra. In that sense, we used ICA to extract the elution profiles and43
then determine the spectra by means of OSD. Finally, ICA-OSD shown itself as a computationally faster alternative44
to MCR-ALS. Up to the date, the capability of independent component analysis - orthogonal signal deconvolution for45
compound quantification in chromatographic signals has not been studied.46
In this paper we propose an automated method to deconvolve compounds appearing in GCxGC-MS samples by47
independent component analysis - orthogonal signal deconvolution.48
2. Materials and methods49
2.1. Materials50
The performance of ICA-OSD was evaluated through a set of 38 metabolites appearing in 20 Jurkat cell samples51
extracted from human acute T cell lymphoblastic leukemia cell line Jurkat. The samples of this experiment were pre-52
viously used to report the intersection of phosphoethanolamine with menaquinone-triggered apoptosis by Styczynski53
et al. [16]. More details on the dataset, sample preparation and methods can be found in the original study.54
2.2. Data analysis and pre-processing55
ICA-OSD was used to automatically extract and deconvolve the compounds concentration profiles and spectra.56
The GCxGC-MS chromatograms were processed by analyzing each modulation cycle separately. Each modulation57
cycle was first divided in chromatographic peak features (CPFs) using the same criteria as in [17]. The different CPFs58
contained several compounds, so the algorithm had to deconvolve them in case of co-elution. The number of factors59
or components for ICA was determined by evaluation of residual sum of squares (described in Section 3.2).60
The chromatograms were automatically processed by ICA-OSD. From the ICA-OSD output we only took into61
account those metabolites appearing in at least 15 of the 20 samples, so a total of 38 compounds with KEGG number62
(Kyoto Encyclopedia of Genes and Genomes) were identified. Metabolite identities were curated by spectral similarity63
with the reference spectra and retention index error by retention time standardization using fatty acid methyl esters64
(FAME) standards. However, the identity was not confirmed with the analysis of reference standards and therefore,65
the list of identified metabolites is putative, and a name is assigned to facilitate the interpretation of the results. For66
this sub-set of 38 compounds, reference relative compound concentration - relative across samples - was determined67
by the area of a selective ion. The most selective ion was manually determined for each compound.68
The spectra determined by ICA–OSD were compared using the dot product [18] against the Golm Metabolome69
Database (GMD) [19] MS spectra library. The masses 73, 74, 75, 147, 148, and 149 m/z were excluded before70
processing the sample, since they are ubiquitous mass fragments typically generated from compounds carrying a71
trimethylsilyl moiety [19]. They were also excluded in the identification. Only the fragments from m/z 70 to 60072
were taken into account when comparing reference and empirical spectra, since this is the m/z range included in the73
downloadable GOLM database. Also, chromatographic signals were filtered using a Savitzky–Golay filter [20]. The74
ICA algorithm used was the joint approximate diagonalization of eigenvalues (JADE) [21].75
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3. Computational methods and theory76
This section describes the ICA-OSD algorithm together with the methodology to determine the number of com-77
pounds.78
3.1. Resolution of GCxGC-MS mixtures by independent component analysis – orthogonal signal deconvolution79
Orthogonal signal deconvolution (OSD) is a multivariate method which purpose is to extract and deconvolve the80
spectrum of a given compound only with the information relative to the compound elution profile. OSD is based on81
principal component analysis, avoiding thus, the use of least squares used in multivariate curve resolution - alternating82
least squares (MCR-ALS). Here, the elution profiles are determined by ICA to later determine the spectra using OSD,83
and in this manner we will refer the complete approach as ICA-OSD.84
ICA is mathematically expressed as:85
X = AZT (1)
where X (N×M) is the matrix containing the mixture of compounds, A (N×k) is the mixing matrix and ZT (k×M)86
is the source matrix. N and M are the number of rows and columns of the data matrix X, and k denotes the number of87
components or compounds in the model. Each row in X holds a m/z channel whereas each column holds the retention88
time scans. ICA decomposes the data matrix by finding the independent sources contained in X.89
As mentioned above, generally ICA-based approaches are based on extracting first the spectra using ICA - the90
spectra are considered the independent sources - to later estimate the elution profile using different approaches. In91
our ICA-OSD implementation, the elution profiles of the compounds are considered the independent sources and thus92
ZT holds the elution profile for each compound. Since the elution profiles determined by ICA may be affected by93
the ICA ambiguity of negativity, the sources in ZT that express more negative variance than positive are negatively94
rotated. Moreover, all the components in ZT are submitted to unimodality constraint to force one local maxima per95
source. ICA has a second ambiguity related to variance (energy) indetermination, which means that the energy of96
the recovered compound profiles do not correspond to the real energy of that component. To overcome that, a least97
squares regression is performed with the estimated sources hold in ZT against the base ion chromatogram of the matrix98
X. The base ion chromatogram or BIC is determined by representing the maximum m/z value for each point in the99
chromatogram.100
Once the elution profiles are determined, OSD is applied to extract each corresponding spectra. In OSD, an X′j101
sub-data matrix is determined for each compound j in ZT . This sub-data matrix comprises only the data from X in102
which the compound profile in ZTj is non-zero - the elution profile in Z
T is used as a mask to suppress the surrounding103
data non-related to the compound -. A PCA is performed over the sub-data matrix to determine the spectra associated104
to each compound. PCA can be mathematically expressed as:105
X′j = YW
T (2)
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where X′(N×M) is the sub-data matrix to decompose, Y(N×M) is the score matrix and W(M×M) is the loading106
or eigenvectors matrix. For each compound profile, the PCA decorrelates the information of the sub-data matrix and107
decomposes it into a matrix WT (Eq. 3) which is a set of orthogonal spectra and a matrix Y which is associated to108
the retention time covariance response for each spectrum in WT . The matrix WT holds the spectra of the compound109
of interest together with the spectra of the different sources of noise - such as co-eluted substances or biological110
matrix interference -. To determine which spectrum is related to the compound of interest we compute the correlation111
between the profile of the compound in ZT j and the information of the covariance responses determined by the PCA112
in Y. The component with the highest absolute correlation is the candidate spectra for the compound of interest.113
OSD can be summarized in the following steps:114
1. Given a ZTj compound elution profile, determine a X j sub-data matrix comprised only of the data of the115
retention time in which the compound is eluting.116
2. Apply a PCA over X j. The result is a score matrix Y and loading matrix W.117
3. Determine the correlation coefficient between ZTj and each component in Y and select the component h with118
the highest absolute correlation value.119
4. Select the component h in W, rotate Wh according to the sign of the previous determined correlation coeffi-120
cient, and clip to zero all the negative values. Wh is now considered to be the spectrum of ZTj .121
After the spectra are determined, the elution profiles are refined by the application of a NNLS regression of all the122
spectra against the data matrix X.123
3.2. Determination of number of components124
To define the ICA model, it requires a fixed number of components. The number of components is closely related125
to the number of compounds present in the mixture, as usually the model to define the data is not only constructed126
by pure compounds but also by baseline, noise, or other interferences. An iterative residual sum of squares (RSS)127
approach was used to automatically determine the number of components for the ICA model. The RSS can be128
expressed as:129
RS S (k) =
N∑
i=1
(X − X∗(k))2 (3)
where, X is the original mixture matrix, X∗(k) is the resolved matrix by ICA-OSD using k components, and N is the130
total length of the unfolded X matrix. For each k in k = 1, 2, ..., N, ICA-OSD resolves the X data with k components131
and it determines the RSS. This method yields a decreasing RSS curve that tends to a minimum. The proper number132
of factors is determined when the addition of more components does not significantly decrease the explained variance,133
i.e., when the RSS error reaches a certain threshold.134
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4. Results and discussion135
The chromatographic data was automatically processed with our proposed method ICA-OSD. Metabolites eluting136
in more than one modulation cycle were associated based on their identity and quantified together (sum of concentra-137
tions). The metabolites across samples were aligned also based on their identity. Table 1 shows the list of the identified138
compounds along with their 1st and 2nd retention times and the identification match factor (MF). The identification139
match factor is determined by dot product between the averaged compound spectra across samples and the reference140
spectra (Golm Metabolome Database GMD). The closer the score to one hundred, the more exact and pure the spectra141
extracted. The table also shows the linear regression coefficient of determination (R2) between our empirical method142
ICA-OSD and the selective ion area (reference model). In order to demonstrate the ICA-OSD quantification capability143
along a wide dynamic range of metabolite concentration, we determined the relative compound concentration (Rel.144
C.) which is the quotient between the mean concentration of each compound and the mean concentration of all the145
compounds listed in the table.146
In this study, we use the coefficient of determination R2 as a metric to describe the relative deviation between147
our proposed method for quantification (ICA-OSD) and our reference model (selective ion). From the given results,148
most of the R2 coefficients are in good agreement (R2>0.90) while up to 24 cases exhibit an excellent linear relation149
(R2>0.95). Overall, ICA-OSD conducted a reliable quantification of compounds even when those occurred at low150
concentration or appeared co-eluted.151
The efficiency of ICA-OSD is directly conditioned by the degree of noise and co-elution with other compounds.152
To illustrate this, and the operation of ICA-OSD for compound deconvolution we shown two different examples of153
co-elution situations in GCxGC-MS. Figure 1 shows the total ion chromatogram (BIC) in dotted grey line, and the154
resolved compound elution profiles by ICA-OSD in color lines, of two selected retention time windows from different155
modulation cycles.156
In Figure 1 (a), three compounds appear under the same chromatographic peak, those three compounds were157
resolved by ICA-OSD and one of them was identified as erythritol (4TMS). Similarly, in Figure 1 (b) three compounds158
appear co-eluted but resolved by ICA-OSD; on of them was identified as myo-inositol (6TMS). The resolved spectra159
for erythritol and myo-inositol are shown in Figure 2 where we can visually compare the empirical (black and positive)160
and the reference (color and negative) spectra. In both cases ICA-OSD successfully extracted the spectra needed to161
properly identify both compounds. In the Figure 1 (a) case, erythritol appears low concentrated and in co-elution162
with a more intense compound. Despite that, ICA-OSD is capable of extracting a sufficient pure spectrum to allow a163
correct identification, with a match score of 98 % - for the given sample case -. In Figure 1 (b), myo-inositol appears164
strongly interfered by another more concentrated compound. As a result, ICA-OSD fails in correctly associate the165
fragments between m/z 100 and 150 (Figure 2 (b)), which appears in the reference spectrum but they do not appear166
in the empirical spectrum. Also, the ions m/z 305 and 318 appears to be interfered, and their relative intensities167
differ from the reference pattern. Consequently, the match score of myo-inositol in this given case is 87 %. This is168
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a clear example of the problems for the correct identification of metabolites that co-elution brings. The identification169
performance can be assessed also in an example of a set of spectra extracted by ICA-OSD shown in Figure 3, where170
we can visually compare the empirical (black and positive) and the reference (color and negative) spectra for each171
compound. The figure shows the spectra extracted for lactic acid (2TMS), phosphoric acid (3TMS), fumaric acid172
(2TMS) and glycerol (3TMS), and this exemplifies the capability of ICA-OSD to successfully extract spectra from173
chromatographic mixtures.174
As mentioned before, one of the most important factors that difficulties the identification is co-elution. In those175
cases, the spectrum of each compound has to be correctly separated - resolved or deconvolved - from co-eluted176
compounds or other noise interferences. Despite that one of the differential characteristics of GCxGC-MS with respect177
to GC-MS is the reduction of the co-elution problem, we still find co-eluted peaks across the second retention time178
dimension. Here we show how ICA-OSD is also an effective method for the resolution of chromatographic signals179
including those generated by GCxGC-MS. Due to noise and other interferences, OSD may fail in correctly classify180
the m/z when deconvolving spectra. This means that OSD would fail in associating a certain m/z to a compound181
where other methods based on least squares, such as MCR-ALS would probably not, as OSD is a more conservative182
approach . On the contrary, OSD brings more accuracy generally in co-eluted situations as attempts to differentiate183
which ions correspond to the compound of interest [15].184
Here we applied ICA-OSD in each modulation cycle separately. We later grouped the compounds appearing in185
different modulation cycles according to their identity. This may also affect the quantification of compounds as the186
same compound can be identified with a different name between or within samples. Automatic alignment or grouping187
of compounds between and within samples after deconvolution is still an important problem that has to be tackled.188
5. Conclusions189
We previously shown that ICA-OSD was able to successfully extract the spectra from co-eluted compounds in190
GC-MS [15], but the capability of ICA-OSD to quantify metabolites was not evaluated. In this study we evaluate a191
method to automatically resolve chromatographic data in GCxGC-MS samples with ICA-OSD. Besides, ICA-OSD192
is an efficient method in terms of speed of execution as previously shown in [15], which is an important advantage193
for GCxGC-MS data processing due to the large amount of data that metabolomics experiments generate with this194
analytical platform. This study concludes that ICA-OSD can be used to resolve co-eluted compounds in GCxGC/MS-195
based metabolomics samples.196
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Figure 1: Two cases of co-elution resolved by ICA–OSD. The dotted grey line represents the BIC whereas the resolved profiles are shown in the
solid-colored line. In (a), erythritol appear in co-elution with other unkown compounds (1, 2). In (b), myo-inositol appear also in co-eluted with an
unkown compound (3, 4).
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Figure 2: Representation of the extracted spectra (black) by ICA-OSD and the reference GMD spectra (color), for the cases shown in Figure 1,
erythritol and myo-inositol. Reference spectra are shown negatively rotated in the same axis for a better visual appreciation.
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Figure 3: Representation of a set of extracted average - across samples - spectra (black) by ICA-OSD and the reference GMD spectra (color).
Reference spectra are shown negatively rotated in the same axis for a better visual appreciation.
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Table 1: List of identified compounds in Jurkat cell samples. MF is the match factor, R2 is the linear regression coefficient, and Rel. C is the relative
concentration.
No. Rt1 Rt2 Name MF R2 Rel. C (%)
1 4.5 1.8 Boric acid (3TMS) 92 0.96 137.28
2 4.58 2.9 Alanine (2TMS) 95 0.82 24.87
3 5.33 1.99 Valine (1TMS) 98 0.92 27.06
4 5.58 2.06 Lactic acid (2TMS) 99 0.99 939.18
5 5.75 2.12 Glycolic acid (2TMS) 98 0.90 61.17
6 5.92 1.94 Ethanolamine (3TMS) 87 0.84 16.26
7 6.5 1.9 Isovaleric acid, 2-oxo- (1MEOX) (1TMS) MP 89 0.98 101.7
8 6.67 2.38 Furan-2-carboxylic acid (1TMS) 98 1.00 25.02
9 7.5 2.78 Phosphoric acid (3TMS) 98 0.97 12.84
10 7.6 1.86 Glycerol (3TMS) 90 0.98 1294.11
11 8.1 2.38 Succinic acid (2TMS) 98 0.85 49.99
12 8.6 2.12 Nonanoic acid (1TMS) 91 0.98 105.88
13 9.1 2.04 Threonine, allo- (3TMS) 98 0.90 12.23
14 9.5 2.48 Aspartic acid (2TMS) 95 0.85 20.99
15 9.6 2.06 Malic acid (3TMS) 72 0.99 13.83
16 9.8 2.11 Decanoic acid (1TMS) 96 1.00 11.63
17 10.6 1.86 Erythritol (4TMS) 97 0.99 56.44
18 11.4 2.48 Proline [+CO2] (2TMS) 99 0.98 7.99
19 11.6 2.54 Hypotaurine (3TMS) 97 0.98 74.63
20 11.8 2.26 Glutamic acid (3TMS) 98 0.99 93.16
21 12.23 3.79 Pyroglutamic acid (2TMS) 99 0.89 112.16
22 12.23 3.05 Proline, 4-hydroxy-, cis- (3TMS) 98 0.82 14.45
23 12.82 4.28 Glutamic acid (2TMS) 97 0.97 17.37
24 13.23 3.26 Glutamic acid (3TMS) 98 0.99 80.1
25 13.48 3.01 Dodecanoic acid (1TMS) 98 0.94 25.84
26 13.9 3.65 Pyrophosphate (4TMS) 96 0.99 5.25
27 14.23 3.94 Glucose, 2-amino-2-deoxy- (4TMS) MP 91 0.99 8.38
28 14.57 2.89 Xylitol (5TMS) 98 0.92 24.63
29 14.98 3.41 Glycerol-3-phosphate (4TMS) 98 0.92 93.59
30 15.4 3 Ornithine (4TMS) 97 1.00 3.95
31 15.57 3.02 Tetradecanoic acid (1TMS) 98 0.97 154.25
32 16.07 3.25 Tyrosine (2TMS) 99 0.84 3.84
33 16.15 2.85 Psicose (1MEOX) (5TMS) BP 99 0.96 270.47
34 16.4 2.85 Glucose (1MEOX) (5TMS) MP 97 1.00 149.68
35 16.48 2.83 Mannose (1MEOX) (5TMS) MP 98 1.00 66.15
36 17.65 2.9 Inositol, allo- (6TMS) 94 0.95 19.81
37 18.98 2.98 Octadecenoic acid, 9-(Z)- (1TMS) 91 0.89 30.99
38 22.9 2.8 Sucrose (8TMS) 94 1.00 3.43
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